| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 1 |
| GO:0005654 | nucleoplasm | 2 | 1 |
| GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
| GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
| GO:0032991 | protein-containing complex | 1 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AI57
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
| GO:0006379 | mRNA cleavage | 7 | 1 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0016070 | RNA metabolic process | 5 | 1 |
| GO:0016071 | mRNA metabolic process | 6 | 1 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0046483 | heterocycle metabolic process | 3 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:0090304 | nucleic acid metabolic process | 4 | 1 |
| GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
| GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
| GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
| GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 7 |
| GO:0003723 | RNA binding | 4 | 7 |
| GO:0005488 | binding | 1 | 7 |
| GO:0097159 | organic cyclic compound binding | 2 | 7 |
| GO:1901363 | heterocyclic compound binding | 2 | 7 |
| GO:0003729 | mRNA binding | 5 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 176 | 180 | PF00656 | 0.640 |
| CLV_NRD_NRD_1 | 357 | 359 | PF00675 | 0.446 |
| CLV_NRD_NRD_1 | 365 | 367 | PF00675 | 0.520 |
| CLV_NRD_NRD_1 | 402 | 404 | PF00675 | 0.543 |
| CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.282 |
| CLV_PCSK_KEX2_1 | 396 | 398 | PF00082 | 0.669 |
| CLV_PCSK_KEX2_1 | 400 | 402 | PF00082 | 0.704 |
| CLV_PCSK_PC1ET2_1 | 396 | 398 | PF00082 | 0.669 |
| CLV_PCSK_PC1ET2_1 | 400 | 402 | PF00082 | 0.704 |
| CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.463 |
| CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.279 |
| CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.279 |
| CLV_PCSK_SKI1_1 | 330 | 334 | PF00082 | 0.518 |
| CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.280 |
| CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.279 |
| CLV_Separin_Metazoa | 355 | 359 | PF03568 | 0.475 |
| DEG_APCC_DBOX_1 | 133 | 141 | PF00400 | 0.464 |
| DEG_SCF_FBW7_1 | 1 | 8 | PF00400 | 0.611 |
| DOC_CYCLIN_yCln2_LP_2 | 307 | 313 | PF00134 | 0.534 |
| DOC_MAPK_gen_1 | 76 | 82 | PF00069 | 0.479 |
| DOC_PP2B_LxvP_1 | 203 | 206 | PF13499 | 0.697 |
| DOC_PP4_FxxP_1 | 333 | 336 | PF00568 | 0.663 |
| DOC_PP4_MxPP_1 | 265 | 268 | PF00568 | 0.696 |
| DOC_PP4_MxPP_1 | 285 | 288 | PF00568 | 0.683 |
| DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.570 |
| DOC_USP7_MATH_1 | 302 | 306 | PF00917 | 0.645 |
| DOC_USP7_MATH_1 | 381 | 385 | PF00917 | 0.643 |
| DOC_USP7_UBL2_3 | 359 | 363 | PF12436 | 0.445 |
| DOC_USP7_UBL2_3 | 367 | 371 | PF12436 | 0.508 |
| DOC_USP7_UBL2_3 | 396 | 400 | PF12436 | 0.621 |
| DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.668 |
| DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.588 |
| DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.536 |
| DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.725 |
| DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.633 |
| LIG_Actin_WH2_2 | 14 | 29 | PF00022 | 0.481 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.552 |
| LIG_eIF4E_1 | 68 | 74 | PF01652 | 0.479 |
| LIG_FHA_1 | 180 | 186 | PF00498 | 0.626 |
| LIG_FHA_2 | 174 | 180 | PF00498 | 0.641 |
| LIG_FHA_2 | 33 | 39 | PF00498 | 0.482 |
| LIG_FHA_2 | 56 | 62 | PF00498 | 0.495 |
| LIG_Integrin_isoDGR_2 | 42 | 44 | PF01839 | 0.279 |
| LIG_LIR_Apic_2 | 331 | 336 | PF02991 | 0.527 |
| LIG_LIR_Gen_1 | 351 | 361 | PF02991 | 0.503 |
| LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.503 |
| LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.411 |
| LIG_PCNA_PIPBox_1 | 155 | 164 | PF02747 | 0.395 |
| LIG_PCNA_yPIPBox_3 | 148 | 162 | PF02747 | 0.399 |
| LIG_SH2_STAP1 | 364 | 368 | PF00017 | 0.501 |
| LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.479 |
| LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.417 |
| LIG_SH3_3 | 199 | 205 | PF00018 | 0.648 |
| LIG_SH3_3 | 331 | 337 | PF00018 | 0.490 |
| LIG_SH3_3 | 84 | 90 | PF00018 | 0.513 |
| LIG_UBA3_1 | 136 | 144 | PF00899 | 0.484 |
| MOD_CK1_1 | 175 | 181 | PF00069 | 0.748 |
| MOD_CK1_1 | 323 | 329 | PF00069 | 0.593 |
| MOD_CK1_1 | 384 | 390 | PF00069 | 0.622 |
| MOD_Cter_Amidation | 74 | 77 | PF01082 | 0.279 |
| MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.811 |
| MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.693 |
| MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.617 |
| MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.674 |
| MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.672 |
| MOD_GlcNHglycan | 374 | 377 | PF01048 | 0.610 |
| MOD_GlcNHglycan | 386 | 390 | PF01048 | 0.640 |
| MOD_GSK3_1 | 1 | 8 | PF00069 | 0.611 |
| MOD_GSK3_1 | 114 | 121 | PF00069 | 0.580 |
| MOD_GSK3_1 | 164 | 171 | PF00069 | 0.598 |
| MOD_GSK3_1 | 173 | 180 | PF00069 | 0.708 |
| MOD_GSK3_1 | 194 | 201 | PF00069 | 0.815 |
| MOD_GSK3_1 | 204 | 211 | PF00069 | 0.654 |
| MOD_GSK3_1 | 227 | 234 | PF00069 | 0.607 |
| MOD_GSK3_1 | 247 | 254 | PF00069 | 0.558 |
| MOD_GSK3_1 | 381 | 388 | PF00069 | 0.788 |
| MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.642 |
| MOD_N-GLC_1 | 328 | 333 | PF02516 | 0.556 |
| MOD_NEK2_1 | 118 | 123 | PF00069 | 0.610 |
| MOD_NEK2_1 | 157 | 162 | PF00069 | 0.482 |
| MOD_NEK2_1 | 208 | 213 | PF00069 | 0.592 |
| MOD_NEK2_1 | 303 | 308 | PF00069 | 0.557 |
| MOD_PIKK_1 | 186 | 192 | PF00454 | 0.539 |
| MOD_PIKK_1 | 293 | 299 | PF00454 | 0.550 |
| MOD_PKA_1 | 396 | 402 | PF00069 | 0.537 |
| MOD_PKA_2 | 396 | 402 | PF00069 | 0.537 |
| MOD_Plk_1 | 17 | 23 | PF00069 | 0.501 |
| MOD_Plk_1 | 328 | 334 | PF00069 | 0.523 |
| MOD_Plk_1 | 37 | 43 | PF00069 | 0.390 |
| MOD_Plk_1 | 381 | 387 | PF00069 | 0.535 |
| MOD_Plk_2-3 | 55 | 61 | PF00069 | 0.480 |
| MOD_Plk_4 | 114 | 120 | PF00069 | 0.569 |
| MOD_Plk_4 | 251 | 257 | PF00069 | 0.683 |
| MOD_Plk_4 | 32 | 38 | PF00069 | 0.479 |
| MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.658 |
| MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.581 |
| MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.529 |
| MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.726 |
| MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.629 |
| MOD_SUMO_rev_2 | 360 | 368 | PF00179 | 0.488 |
| MOD_SUMO_rev_2 | 388 | 398 | PF00179 | 0.618 |
| TRG_DiLeu_BaEn_1 | 132 | 137 | PF01217 | 0.451 |
| TRG_DiLeu_BaLyEn_6 | 131 | 136 | PF01217 | 0.455 |
| TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.645 |
| TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.479 |
| TRG_NLS_MonoExtC_3 | 399 | 404 | PF00514 | 0.622 |
| TRG_NLS_MonoExtN_4 | 397 | 404 | PF00514 | 0.621 |
| TRG_Pf-PMV_PEXEL_1 | 134 | 138 | PF00026 | 0.463 |
| TRG_Pf-PMV_PEXEL_1 | 366 | 370 | PF00026 | 0.511 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P353 | Leptomonas seymouri | 51% | 100% |
| A0A3Q8IE55 | Leishmania donovani | 86% | 99% |
| A4HXP8 | Leishmania infantum | 85% | 99% |
| E9ARF9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 99% |
| Q4QE20 | Leishmania major | 84% | 100% |